Top Story

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014

BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he participated in at the Cardiometabolic Health Congress on PCSK9 as a target for cholesterol-lowering therapy.

Davidson, clinical professor of medicine and director of the lipid clinic at the University of Chicago Pritzker School of Medicine, noted that in less than a decade since discovering that PCSK9 deficiencies led to reduced LDL cholesterol and CV risk, multiple clinical trials have indicated the effectiveness of PCSK9 as an LDL-lowering therapy. He also addressed the lowering of LDL as a target of therapy, and acknowledged that several outcome trials assessing this possibility are currently underway.

figure Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

October 24, 2014
BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD are still unclear…
figure Meeting News Coverage

Expert examines contribution of aldosterone in obesity-related hypertension

October 24, 2014
BOSTON — At the Cardiometabolic Health Congress, Colleen M. Majewski, MD, discussed the link between elevated aldosterone and obesity-related hypertension, and…
figure Meeting News CoverageVideo

Experts tackle racial, ethnic disparities in cardiometabolic health

October 23, 2014
BOSTON — In this video, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of Medicine in New Orleans, discusses racial and…
CME
figure

Managing Antiplatelet Therapy in Patients on Proton Pump Inhibitors: Understanding Drug Interactions and Cardiovascular Implications

This activity is supported by an educational grant from Takeda.

Patients receiving antiplatelet therapy are at an increased risk of gastrointestinal bleeding. Proton pump inhibitors…
More »
Meeting News Coverage Video
figure

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he…
More »
CME
figure

Practical Lipidology: 2013

This activity is supported by an educational grant from Genentech.

The rise in the prevalence of obesity in the last few decades and its growing impact on health has driven the…
More »

Filter By:

figure Meeting News Coverage Video

Michael H. Davidson, MD, discusses PCSK9 as a target of therapy

October 24, 2014
BOSTON — In this video, Cardiology Today Editorial Board member Michael H. Davidson, MD, outlines a session he participated in at the…
figure Meeting News Coverage

Efficacy, safety of aspirin for treatment of patients with diabetes, CAD unclear

October 24, 2014
BOSTON — The benefits of using aspirin, alone or with a platelet inhibitor, for the treatment of patients with diabetes at high-risk for CVD…
figure Meeting News Coverage

Expert examines contribution of aldosterone in obesity-related hypertension

October 24, 2014
BOSTON — At the Cardiometabolic Health Congress, Colleen M. Majewski, MD, discussed the link between elevated aldosterone and obesity-related…
figure Meeting News Coverage Video

Experts tackle racial, ethnic disparities in cardiometabolic health

October 23, 2014
BOSTON — In this video, Keith C. Ferdinand, MD, FACC, professor of clinical medicine at Tulane University School of Medicine in New Orleans…
figure Meeting News Coverage

Cardiometabolic Health Congress highlights latest research on CVD, diabetes, obesity

October 23, 2014
BOSTON — The latest innovative research in diabetes, hypertension, lipids, obesity and thrombosis was analyzed by experts at the…
figure Meeting News Coverage

New trials underway to explore impact of anti-inflammatory therapy on CV events

October 23, 2014
BOSTON — Multiple studies have suggested that measures of inflammatory biomarkers may be predictive of CV events, and the question remains…
figure Meeting News Coverage

Misinterpretation of cholesterol, risk-assessment guidelines may produce unintended consequences

October 23, 2014
BOSTON — Misinterpretation of the 2013 American College of Cardiology/American Heart Association guidelines on cholesterol management and CV…
Meeting News Coverage

Vitamin D levels predicted neurologic outcomes after sudden cardiac arrest

October 22, 2014
Vitamin D deficiency increased the risk for poor neurologic outcomes after sudden cardiac arrest, according to new data reported at Acute…
In the Journals

Low levels of DHEA predicted CHD risk in elderly men

October 22, 2014
Low serum levels of the adrenal sex hormone dehydroepiandrosterone and its sulfate were predictors of increased risk for CHD events in elderly men…
In the Journals

NT-proBNP levels improved CVD risk prediction in women

October 22, 2014
N-terminal pro–B-type natriuretic peptide modestly improved measures of CVD risk prediction in women with numerous CV events, according to new…
More Headlines »